Evidence map›Paper›PMID 34531843›Full record

ArticleFrontiers in microbiology2021

Detection of Colistin Resistance in

Katy Jeannot, Katheryn Hagart, Laurent Dortet, Markus Kostrzewa, Alain Filloux, Patrick Plesiat, Gerald Larrouy-Maumus

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  3. Article
  4. Mutational Analysis of Colistin-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Multidrug ResistantPathogens (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Antimicrobial resistance genes harbored in invasiveFrontiers in cellular and infection microbiology · 2024
    Article
  12. Review
  13. Two-site study on performances of a commercially available MALDI-TOF MS-based assay for the detection of colistin resistance in Escherichia coli.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  14. The Impact of the Virulence ofVeterinary sciences · 2023
    Article
  15. Antimicrobial resistance and genotyping ofFrontiers in veterinary science · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Katy JeannotUMR 6249 Chrono-Environnement, UFR Sciences Médicales et Pharmaceutiques, University of Bourgogne-Franche Comté, Besançon, France.
Katheryn HagartDepartment of Life Sciences, Faculty of Natural Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Laurent DortetFrench National Reference Centre for Antibiotic Resistance, Besançon, France.
Markus KostrzewaBruker Daltonik GmbH, Bremen, Germany.
Alain FillouxDepartment of Life Sciences, Faculty of Natural Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Patrick PlesiatUMR 6249 Chrono-Environnement, UFR Sciences Médicales et Pharmaceutiques, University of Bourgogne-Franche Comté, Besançon, France.
Gerald Larrouy-MaumusDepartment of Life Sciences, Faculty of Natural Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Imperial College London · GBCentre Hospitalier Universitaire de Besançon · FRBruker (Germany) · DEUniversité Paris-Sud · FR

Funding

Medical Research Council MC_PC_15028Medical Research Council MC_PC_17162Wellcome Trust
6 · The paper itself

Abstract

Colistin is frequently a last resort treatment for

Indexed as

clinical isolatecolistinlipid AMALDI mass spectrometryPseudomonas aeruginosa

Identifiers

PMID34531843
PMCPMC8438524
OpenAlexW3197044448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.